Jennifer Mytych
 Email src
Zakład Genetyki, Zamiejscowy Wydział Biotechnologii Uniwersytetu Rzeszowskiego, Polska

Abstract

In the era of intensive development of lifestyle diseases such as stomach cancer, it is crucial to design markers that enable their early detection, allow rapid introduction of treatment and prevent the increase in the number of deceases. Potential possibility is microRNAs, short RNA molecules which modulate the activity of specific fragments of RNA and play an important role in many physiological and pathological processes. Affecting cell proliferation, cell cycle and apoptosis of cancer cells also play a significant role in neoplasia. Detectable levels of derogation from the regular level associated with each of the stages of tumor development may make them effective and non-invasive biomarkers, allowing not only for early detection and identification of cancer’s type, but also on their prediction. Further understanding of their functions and properties can result in the discovery of effective methods of cancer treatment.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited